(2S,4R)-Ethyl 4-methylpiperidine-2-carboxylate

Catalog No. :
ACBQFV493
CAS No. :
79199-62-5
Molecular Formula :
C9H17NO2
Molecular Weight :
171.24

IUPAC Name:ethyl (2S,4R)-4-methylpiperidine-2-carboxylate

(2S,4R)-Ethyl 4-methylpiperidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$99.00Login to see priceIn stockInquiry
1g97%$289.00Login to see priceIn stockInquiry
5g97%$1273.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,4R)-Ethyl 4-methylpiperidine-2-carboxylate
IUPAC Nameethyl (2S,4R)-4-methylpiperidine-2-carboxylate
MDL No.MFCD27977908
Molecular FormulaC9H17NO2
Molecular Weight171.24
SMILESO=C([C@H]1NCC[C@@H](C)C1)OCC
InChI KeyGHBNOCBWSUHAAA-SFYZADRCSA-N
Synonym(2S,4R)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester;(2S-cis)-4-Methyl-2-piperidinecarboxylic Acid Ethyl Ester;Ethyl (2S,4R)-4-Methylpipecolate;ethyl (2R,4S)-4-methyl-2-pipecolate;Argatroban Impurity 39;Argatroban Impurity 39 (Ethyl (2S,4R)-4-Methylpipecolate);Ethyl (2R,4S)-4-methyl-2-piperidinecarboxylate;Argatroban Related Compound 2
CAS No.79199-62-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P210-P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACBQFV493 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQFV493 route product structure diagram
    ACBQFV49379199-62-5 In Stock
Inquiry

2. ACBQFV493 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQFV493 route product structure diagram
    ACBQFV49379199-62-5 In Stock
Inquiry

Comments (0)